What will it take to promote vaccine development in Africa?

Published Date: 02 Mar 2023

The COVID-19 pandemic has highlighted the importance of vaccines in controlling the epidemic in sub-Saharan Africa and a renewed interest in vaccine research and development across the country.

Read Full News

Latest News

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

6 Ophthalmology Headlines You Missed in October 2025

6 Ophthalmology Headlines You Missed in October 2025

New Parameters for Faster Geographic Atrophy Progression Established, with Srinivas Sadda, MD Srinivas Sadda, MD

The pooled sham cohorts of the OAKS and DERBY trials have revealed a series of indicators for faster geographic atrophy lesion growth.

OCU-410 Gene Therapy Preserves Visual Acuity and Slows GA Lesion Progression, with Jay Chhablani, MD Jay Chhablani, MD

Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.

Intravitreal UBX1325 Shows Efficacy in Diabetic Retinopathy, DME, with Dante Pieramici, MD Dante J. Pieramici, MD

Results from the BEHOLD and ASPIRE trials indicate the long lasting effects of UBX1325 in improving retinal function and structure.

Todays Updates

Adults with Developmental and Epileptic Encephalopathies in the Precision Treatment Era Danielle Andrade, MD, MSc

Explore the evolving landscape of developmental and epileptic encephalopathies in adults, highlighting precision therapies and the need for accurate diagnoses.

What’s All the Buzz? Trending Topics and Phrases of Neurology in 2025 Marco Meglio

Explore the transformative buzzwords in neurology for 2025, highlighting advancements in AI, gene therapy, personalized treatment, and neuroplasticity.

Todays Updates

Adults with Developmental and Epileptic Encephalopathies in the Precision Treatment Era Danielle Andrade, MD, MSc

Explore the evolving landscape of developmental and epileptic encephalopathies in adults, highlighting precision therapies and the need for accurate diagnoses.

What’s All the Buzz? Trending Topics and Phrases of Neurology in 2025 Marco Meglio

Explore the transformative buzzwords in neurology for 2025, highlighting advancements in AI, gene therapy, personalized treatment, and neuroplasticity.

Latest News

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

6 Ophthalmology Headlines You Missed in October 2025

The pooled sham cohorts of the OAKS and DERBY trials have revealed a series of indicators for faster geographic atrophy lesion growth.

Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.

Results from the BEHOLD and ASPIRE trials indicate the long lasting effects of UBX1325 in improving retinal function and structure.

News All Time

Childhood blindness: Recommended realignment of prevention, medical treatment in development cooperation

International health policy and German development cooperation focus primarily on preventive measures. This is evident, for example, in diseases such as childhood blindness, which can be prevented through vaccinations or ...

Demystifying a visual illusion: Why we see color that's not there

A new discovery has unraveled why we sometimes see colors that aren't there. The phenomenon of "color afterimages" is when you see illusory—or false—colors after staring at real colors for a longer time. Through this, ...

Better vision test enables precise detection of eye disorders in toddlers

The development of a new tool for testing the eyesight of children under three could mean more children receive treatment for vision difficulties earlier, leading to positive effects on learning and development.

Eye scans reveal clues to aging and heart disease risk, study finds

The tiny blood vessels in your eyes might hold the key to predicting a person's risk of developing heart disease and how fast they're biologically aging, according to researchers at McMaster University and Population Health ...

LASIK armed with 3D eye model provides better vision correction

An advanced form of LASIK (Laser-Assisted In-Situ Keratomileusis) eye surgery that uses a virtual 3D model of a person's eye appears to offer patients better vision, a new study says.

Fancy dress contact lenses can cause infections, ulcers, even blindness—how to keep your eyes safe this Halloween

With Halloween just around the corner, thousands will be shopping for fancy dress contact lenses to go with their costume. The appeal is clear, as their endless colors and shapes allow you to radically change how you look—who ...

Cataract surgery becoming an in-office procedure, experts say

Imagine popping by your eye doctor's office for a quick cataract surgery.

Age-related macular degeneration: Robot delivers ultra-precision injections with rapid setup times

Many surgeons admit that medical robots can now operate with greater precision than human specialists. However, the complex preparation required for robotic surgery still takes far too long. But a new robotic assistant for ...

Risk of eye disease increases during menopause transition

Many symptoms, such as hot flashes and vaginal dryness, are commonly associated with the menopause transition. One of the lesser-known symptoms that worsens in midlife is dry eyes. A new study suggests that postmenopausal ...

Pickleball popularity surge serves up spike in serious eye injuries

Rutgers New Jersey Medical School-led researchers have identified a striking rise in pickleball-related eye injuries among players visiting emergency departments across the United States. Using two decades of national surveillance ...

Transformative eye research expands donor pool for corneal transplant patients

Many eye banks won't accept corneas from donors with diabetes, concerned they might be harder to prepare for transplant surgery or are more likely to fail.

Like radar, a brain wave sweeps a cortical region to read out information held in working memory

Imagine you are a security guard in one of those casino heist movies where your ability to recognize an emerging crime will depend on whether you notice a subtle change on one of the many security monitors arrayed on your ...

Patient wealth is associated with quality of glaucoma care

Patients with newly diagnosed glaucoma who have less wealth or reside in rural communities are less likely to receive standard glaucoma care compared to wealthier patients, according to a recent multi-institutional study ...

FDA authorizes Essilor Stellest eyeglass lenses for children with myopia

The U.S. Food and Drug Administration has authorized marketing of the Essilor Stellest eyeglass lenses to correct myopia, with or without astigmatism, and to slow the progression of the disease in children 6 to 12 years old.

Vision therapy reverses concussion-related double and blurred vision, study finds

Nearly half of adolescents and young adults with lingering symptoms of concussion suffer from eye coordination disorders that cause double and blurred vision, headaches and difficulties concentrating.

Polyunsaturated fatty acid therapy reverses age-related vision decline in mice

Changes in vision are often a common sign of aging. But what if we could reverse age-related visual decline? In a new study, UC Irvine researchers explore a possible therapy for addressing "aging" in the eye and for preventing ...

Recommended News For You

'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma

Discovery of breast cancer treatment resistance mechanism could lead to new hope for some

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

Study finds higher breast cancer rates in areas with more air pollution

Nuclear missile workers are contracting cancer: They blame the bases

New drug combination shows good results in patients with HPV-negative head and neck cancer

Scientists call into question safety of potential new anticancer treatment

Recommended Articles For You

Asymptomatic Thrombocytopenia: Unraveling the Enigma of Low Platelet Counts Without Symptoms 

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment 

Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders 

The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

2.

Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer

3.

Cancerous breast tissue glows in new AI-enhanced MRI images

4.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

5.

enhancing survivors of brain tumors' quality of life.

1.

Decoding Efficacy, Safety, and Future Frontiers in CAR-T Cell Therapy for Hematologic Malignancies Towards CAR-T Therapy 2025

2.

The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder 

3.

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?

4.

The Miracle of Thyrogen Injection: A New Hope for Thyroid Cancer Treatment

5.

From Birthmarks to Tumors: The Science Behind Infantile Hemangioma 

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

3.

Efficient Management of First line ALK-rearranged NSCLC - Part III

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

5.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot